MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,837K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net loss/(gain) on disposal of a...
Accounts payable
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Net loss
Gain on the termination of an op...
Operating lease liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Amortization of bond premium
-
-
0
-
Impairment charges of goodwill and other intangible assets
-
-
0
-
Impairment charges of other assets
-
-
0
-
Net loss
-1,326
-1,921
-1,912
-1,532
Income tax benefit
-
-
0
-
Depreciation and amortization
-
0
3
-1
Net loss/(gain) on disposal of assets
-248
-
-
0
Change in fair value of warrant liability
-
0
0
0
Stock-based compensation expense
104
113
217
253
Change in operating lease right-of-use assets
3
74
91
111
Change in finance lease right-of-use assets
1
0
1
1
Net gain on disposal of assets
-
-
37
-
Gain on the termination of an operating lease
368
-
-
-
Loss on operating lease right-of-use assets modification
-
-
241
-
Operating lease liabilities
-365
-165
-484
-195
Prepaid expenses and other current assets
-35
341
-141
-205
Accounts payable
132
397
235
-86
Accrued expenses and other liabilities
-190
242
-115
-230
Net cash used in operating activities
-1,836
-1,601
-1,509
-1,474
Purchases of marketable debt securities
-
-
0
-
Proceeds from sales of marketable debt securities
-
-
0
-
Proceeds from sale of assets
-
-
15
320
Net cash provided by (used in) investing activities
-
0
15
320
Net proceeds from public offerings of common stock and warrants
-
-
0
-
Gross proceeds from private placement of preferred stock and common stock warrants
-
0
0
0
Transaction costs paid pursuant to private placement
-
0
0
0
Net proceeds from exercise of warrants
-
-
65
64
Payments of finance lease liability principal
1
0
7
0
Net cash (used in) provided by financing activities
-1
0
58
64
Net decrease in cash, cash equivalents and restricted cash
-
-1,601
-1,436
-
Net decrease in cash, cash equivalents and restricted cash
-1,837
-1,601
-1,436
-1,090
Cash, cash equivalents and restricted cash at beginning of period
2,648
4,249
5,685
7,534
Cash, cash equivalents and restricted cash at end of period
811
2,648
4,249
5,685
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in
cash, cash...
-$1,837K
(-142.03%↓ Y/Y)
Net loss/(gain) on
disposal of assets
-$248K
(-325.45%↓ Y/Y)
Accounts payable
$132K
(85.92%↑ Y/Y)
Stock-based compensation
expense
$104K
(-81.19%↓ Y/Y)
Prepaid expenses and
other current assets
-$35K
(89.03%↑ Y/Y)
Change in operating
lease right-of-use...
$3K
(-98.62%↓ Y/Y)
Change in finance lease
right-of-use assets
$1K
(-50.00%↓ Y/Y)
Net cash used in
operating activities
-$1,836K
(54.42%↑ Y/Y)
Net cash (used in)
provided by financing...
-$1K
(-100.03%↓ Y/Y)
Canceled cashflow
$523K
Net loss
-$1,326K
(80.79%↑ Y/Y)
Gain on the
termination of an operating...
$368K
Operating lease
liabilities
-$365K
(-0.55%↓ Y/Y)
Payments of finance lease
liability principal
$1K
(-50.00%↓ Y/Y)
Accrued expenses and
other liabilities
-$190K
(81.15%↑ Y/Y)
something is missing
-$110K
Buy us a coffee
Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. (MTNB)